These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4887986)

  • 1. [Pharmacotherapy, its progress and the problems it poses].
    Martin E
    Pharm Acta Helv; 1968 Sep; 43(9):606-18. PubMed ID: 4887986
    [No Abstract]   [Full Text] [Related]  

  • 2. [Placebos and double-blind studies: significant differences].
    Schelling JL
    Rev Med Suisse Romande; 1969 Sep; 89(9):905-9. PubMed ID: 4921157
    [No Abstract]   [Full Text] [Related]  

  • 3. What happened to drug trials in ulcerative colitis? Problems, PPARs, placebos, and (possible) progress.
    Kornbluth A
    Am J Gastroenterol; 2001 Dec; 96(12):3232-4. PubMed ID: 11774930
    [No Abstract]   [Full Text] [Related]  

  • 4. [The significance of placebos in clinical therapeutic research].
    Schindel L
    Arzneimittelforschung; 1965 Aug; 15(8):936-40. PubMed ID: 5324485
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical trial of drugs (2): principles and problems].
    Janson J; Johnsson G; Sölvell L
    Lakartidningen; 1970 Jun; 67():Suppl II:44+. PubMed ID: 4920749
    [No Abstract]   [Full Text] [Related]  

  • 6. [Some problems posed by double-blind investigation of psychotropic drugs: clinical trial of Nobrium Roche].
    Chistoni GC
    Schweiz Arch Neurol Neurochir Psychiatr; 1971; 108(2):309-15. PubMed ID: 4941608
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic trials in man].
    Schwartz D
    Bull Cancer; 1974; 61(2):177-84. PubMed ID: 4619023
    [No Abstract]   [Full Text] [Related]  

  • 8. [Methods for the determination of drug effects].
    Sato Y
    Saishin Igaku; 1968 Feb; 24(2):349-51. PubMed ID: 4890948
    [No Abstract]   [Full Text] [Related]  

  • 9. [Practical considerations on the use of crossover drawing in clinical experimentation].
    Lucchelli PE; Colombi A
    Boll Chim Farm; 1970 Mar; 109(3):222-32. PubMed ID: 4922965
    [No Abstract]   [Full Text] [Related]  

  • 10. Double blind intensive safety and tolerance studies during quinestrol therapy in elderly women.
    Cohen A
    Int J Fertil; 1967; 12(2):266-70. PubMed ID: 5340518
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of clinical-therapeutic studies].
    Rahlfs V
    Med Welt; 1970 Dec; 50():2135-41. PubMed ID: 4924418
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of prior information in the testing of new drugs.
    Allen DM
    Biometrics; 1971 Sep; 27(3):699-708. PubMed ID: 4940382
    [No Abstract]   [Full Text] [Related]  

  • 13. [Necessity of clinically controlled studies for the development of new drugs].
    Lüthy E; Joyce CR
    Ther Umsch; 1971 Apr; 28(4):246-9. PubMed ID: 4930184
    [No Abstract]   [Full Text] [Related]  

  • 14. Principles for the clinical evaluation of drugs. Report of a WHO Scientific Group.
    World Health Organ Tech Rep Ser; 1968; 403():1-32. PubMed ID: 4972959
    [No Abstract]   [Full Text] [Related]  

  • 15. [Flunarizine in the therapy of chronic cerebrovascular insufficiency. Multicentric controlled study].
    Arrigo A; Lottici P; Alfonsi E; Terraneo GB
    Clin Ter; 1984 Sep; 110(6):541-8. PubMed ID: 6238768
    [No Abstract]   [Full Text] [Related]  

  • 16. The design of drug trials with neurotic patients.
    Kellner R
    Behav Neuropsychiatry; 1970; 2(1):12-9. PubMed ID: 4913956
    [No Abstract]   [Full Text] [Related]  

  • 17. Demonstration of tolerance to and physical dependence of N-allylnormorphine (nalorphine).
    Martin WR; Gorodetzky CW
    J Pharmacol Exp Ther; 1965 Dec; 150(3):437-42. PubMed ID: 5322321
    [No Abstract]   [Full Text] [Related]  

  • 18. Tolerance to beta-adrenergics and results of rising dose studies of albuterol, isoproterenol and placebo.
    Spector S
    Ann Allergy; 1981 Nov; 47(5 Pt 2):394-401. PubMed ID: 7030154
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular toxicity: clinical evaluation of albuterol, isoproterenol and placebo in rising dose tolerance trial.
    Finch JS
    Ann Allergy; 1981 Nov; 47(5 Pt 2):402-4. PubMed ID: 7030155
    [No Abstract]   [Full Text] [Related]  

  • 20. Instant experience in clinical trials: a novel aid to teaching by simulation.
    Maxwell C; Domenet JG; Joyce CR
    J Clin Pharmacol New Drugs; 1971; 11(5):323-31. PubMed ID: 4935713
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.